1. Home
  2. AGFY vs CASI Comparison

AGFY vs CASI Comparison

Compare AGFY & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGFY
  • CASI
  • Stock Information
  • Founded
  • AGFY 2016
  • CASI 1991
  • Country
  • AGFY United States
  • CASI China
  • Employees
  • AGFY N/A
  • CASI N/A
  • Industry
  • AGFY Military/Government/Technical
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGFY Consumer Discretionary
  • CASI Health Care
  • Exchange
  • AGFY Nasdaq
  • CASI Nasdaq
  • Market Cap
  • AGFY 41.0M
  • CASI 31.0M
  • IPO Year
  • AGFY 2021
  • CASI 1996
  • Fundamental
  • Price
  • AGFY $27.42
  • CASI $1.94
  • Analyst Decision
  • AGFY
  • CASI Strong Buy
  • Analyst Count
  • AGFY 0
  • CASI 1
  • Target Price
  • AGFY N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • AGFY 47.5K
  • CASI 8.8K
  • Earning Date
  • AGFY 05-20-2025
  • CASI 05-20-2025
  • Dividend Yield
  • AGFY N/A
  • CASI N/A
  • EPS Growth
  • AGFY N/A
  • CASI N/A
  • EPS
  • AGFY N/A
  • CASI N/A
  • Revenue
  • AGFY $9,680,000.00
  • CASI $28,537,000.00
  • Revenue This Year
  • AGFY N/A
  • CASI N/A
  • Revenue Next Year
  • AGFY N/A
  • CASI N/A
  • P/E Ratio
  • AGFY N/A
  • CASI N/A
  • Revenue Growth
  • AGFY N/A
  • CASI N/A
  • 52 Week Low
  • AGFY $2.71
  • CASI $1.64
  • 52 Week High
  • AGFY $84.44
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • AGFY 74.76
  • CASI 46.90
  • Support Level
  • AGFY $19.60
  • CASI $1.64
  • Resistance Level
  • AGFY $27.67
  • CASI $2.14
  • Average True Range (ATR)
  • AGFY 3.02
  • CASI 0.10
  • MACD
  • AGFY 1.18
  • CASI -0.01
  • Stochastic Oscillator
  • AGFY 94.29
  • CASI 53.12

About AGFY Agrify Corporation

Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: